08:00 , Feb 15, 2016 |  BC Week In Review  |  Company News

Biovica, Karolinska Institute deal

The companies partnered to evaluate the efficacy of two 7,8-dihydro-8-oxoguanine triphosphatase ( NUDT1 ; MTH1) inhibitor cancer therapies from the institute using Biovica’s DiviTum assay. DiviTum measures cell proliferation rates. The institute declined to disclose...
08:00 , Dec 21, 2015 |  BC Week In Review  |  Company News

Biovica, SimplicityBio deal

The companies partnered non-exclusively to combine Biovica’s DiviTum assay with SimplicityBio’s Biomarker Optimization Software System (BOSS) to discover, develop and commercialize improved multi-biomarker panels worldwide for advanced solid tumors. DiviTum measures cell proliferation rates for...